Foster Victor Wealth Advisors
RPRX icon

Foster Victor Wealth Advisors’s Royalty Pharma RPRX Stock Holding History

Foster Victor Wealth Advisors’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$14.9M Buy
246,728
+33,055
+15% +$1.95M 0.74% 58
2026
Q2 		$11.9M Buy
213,673
+6,551
+3% +$341K 0.62% 70
2026
Q1 		$10.1M Buy
207,122
+26,465
+15% +$1.16M 0.58% 72
2025
Q4 		$7.14M Buy
+180,657
New +$6.89M 0.42% 92

Other funds holding RPRX

Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
New South Capital Management
New South Capital Management Memphis, Tennessee $1.53B AUM 36.31% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

Foster Victor Wealth Advisors's RPRX Position: Q3 2026 in Review

Foster Victor Wealth Advisors increased its Royalty Pharma (RPRX) stake by 15% in Q3 2026, buying an estimated $1.95M and bringing the position to 246,728 shares worth $14.9M. The position accounts for 0.74% of the portfolio, ranked #58.

Foster Victor Wealth Advisors first reported a position in RPRX in Q4 2025 and has held it in 4 quarters since. 347 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Foster Victor Wealth Advisors held 246,728 shares of Royalty Pharma worth $14.9M as of Q3 2026.
  • Foster Victor Wealth Advisors bought 33,055 Royalty Pharma shares in Q3 2026, an estimated $1.95M.
  • Royalty Pharma made up 0.74% of Foster Victor Wealth Advisors's portfolio in Q3 2026, its #58 holding.
  • Foster Victor Wealth Advisors first reported a position in Royalty Pharma in Q4 2025 and has held it in 4 quarters since.
  • 347 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Foster Victor Wealth Advisors's 13F filing for Q3 2026, filed 21 Oct 2026.